Carbapenemase Gene Dynamics in CREC Across Guangdong

Study Background and Research Question

Carbapenem-resistant Enterobacter cloacae (CREC) is an important component of the broader carbapenem-resistant Enterobacterales burden. Carbapenemase-encoding genes (CEGs) are especially concerning because they can reduce susceptibility to carbapenems while also traveling on mobile genetic elements and plasmids that carry additional resistance determinants. The clinical significance of a resistant isolate therefore depends not only on which gene is present, but also on whether that gene is chromosomal, plasmid-borne, transferable, or linked to a disseminating clone.

The reference study by Chen and colleagues examined these questions in isolates collected from eight teaching hospitals in Guangdong province, China, between December 2022 and June 2024. The authors framed the work in the context of the COVID-19 period, when antibiotic exposure, disrupted healthcare systems, and complex hospital infections could intensify selection and transmission pressure. The central research question was how frequently CEGs occurred in CREC, where they were located, how readily they transferred, and whether resistance dissemination reflected mobile gene exchange, clonal expansion, or both. The cohort included 54 CREC isolates, as reported in the reference study.

Key Innovation from the Reference Study

The study’s principal innovation is its integrated transmission framework. Rather than treating carbapenem resistance as a single phenotype, it connected five evidence layers: molecular detection of CEGs, plasmid-versus-chromosome localization, antimicrobial susceptibility testing, conjugative transfer, and strain relatedness by ERIC-PCR. This design is valuable because a gene detected by PCR does not by itself demonstrate that the gene is plasmid-mediated or epidemiologically mobile.

The work also separates two mechanisms of dissemination that are often conflated. Conjugation experiments address horizontal movement of resistance genes between bacterial cells, whereas ERIC-PCR clustering provides an indication of vertical or clonal spread among related isolates. Combining both approaches allows the investigators to ask whether hospitals are facing repeated introduction of similar clones, independent acquisition of mobile genes, or simultaneous activity of both processes. The paper further adds mobile genetic element profiling and patient or specimen distribution, extending the analysis beyond a simple prevalence estimate.

Methods and Experimental Design Insights

The experimental workflow was organized around the biological questions being tested. Variable-temperature sodium dodecyl sulfate plasmid elimination was used to help infer whether detected carbapenemase genes were associated with plasmids or chromosomes. PCR then identified the relevant CEGs in the original and treated isolates. This combination is more informative than PCR alone, although it remains an indirect localization method unless supported by complete plasmid sequencing.

Broth microdilution was used to compare antimicrobial susceptibility between CEG-positive and CEG-negative groups. The authors evaluated imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin. This phenotype-genotype comparison tests whether carriage of a CEG is associated with a broader multidrug-resistant profile rather than only with carbapenem nonsusceptibility.

Plasmid conjugation experiments provided a functional test of mobility. PCR analysis of transconjugants was then used to determine which genes had transferred. In parallel, six mobile genetic element types were assessed, including ISEcp1, while ERIC-PCR and NTSYS software were used to group the 54 isolates into related genotypes. This multi-method approach gives the study a useful hierarchy of evidence: detection indicates presence, elimination suggests genetic location, conjugation demonstrates transfer under experimental conditions, and typing indicates population relatedness.

Protocol Parameters

• Study population: The literature-backed cohort consisted of 54 CREC isolates from eight teaching hospitals sampled from December 2022 through June 2024; this defines the study population rather than a universal prevalence estimate.
• Gene localization: The reported workflow used variable-temperature SDS plasmid elimination followed by PCR to compare CEG detection before and after plasmid curing.
• Resistance phenotyping: Broth microdilution was used to compare susceptibility patterns between CEG-positive and CEG-negative isolates, with interpretation linked to the study’s reported testing framework.
• Transfer assessment: Conjugation followed by PCR was used to test whether identified CEGs could move into a recipient background; transfer results should be interpreted as laboratory mobility evidence, not direct proof of transmission in patients.
• Population structure: ERIC-PCR and NTSYS-based clustering were used to examine strain relatedness, while mobile-element PCR added context about the genetic environment surrounding resistance.
• Workflow recommendation: In a comparable investigation, report localization, phenotype, transfer, mobile-element context, and strain relatedness as separate evidence layers rather than using one assay as a proxy for all transmission mechanisms.

Core Findings and Why They Matter

CEGs were detected in 46 of 54 isolates, corresponding to 85.19% of the cohort. The dominant determinant was blaNDM-1. Eighteen isolates carried blaNDM-1 on both chromosomes and plasmids, while 25 carried it exclusively on plasmids. Two isolates carried only plasmid-associated blaIMP, and one carried plasmid-associated blaNDM-1 together with blaKPC-2. These distributions show why gene localization matters: plasmid-only blaNDM-1 is particularly relevant to horizontal dissemination, whereas dual chromosomal and plasmid carriage may provide both persistence and mobility. These results are reported in the primary article.

The CEG-positive group had significantly higher resistance rates to imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin than the CEG-negative group, with significance reported at P < 0.05. The interpretation is not that every resistance phenotype was caused by a single carbapenemase gene. Instead, CEG carriage marked isolates with a substantially more difficult multidrug-resistance profile, likely reflecting the accumulation of resistance mechanisms on mobile or accessory genetic elements.

The conjugation experiments provided one of the clearest practical findings. CEG transfer succeeded in 44 of 46 gene-positive isolates, or 95.65%. Transfer was observed for blaNDM-1 in 42 of 44 tested cases and for blaIMP in both tested cases, whereas the single blaKPC-2-positive isolate did not produce a successful transfer event. The high overall rate supports the conclusion that many of the detected determinants were experimentally mobile, although the unequal number of isolates tested for each gene limits direct comparison among gene types.

ISEcp1 was the most prevalent of the six assessed mobile genetic elements, detected in 47 of 54 isolates, or 87.04%. Twenty-two isolates, representing 40.74% of the cohort, carried four mobile-element types simultaneously. This genetic context is important because resistance risk may be shaped by the combination of a carbapenemase gene with insertion sequences and other mobilization systems rather than by the enzyme gene alone.

ERIC-PCR divided the isolates into 17 genotypes. Types E and G were each represented by 11 isolates, or 20.37%, and isolates in these groups came from different departments in five hospitals. Two type E isolates shared a Dice coefficient of 100%. These findings suggest that clonal relatedness contributed to the epidemiology, but the presence of highly transferable plasmid-associated genes means that clonal surveillance alone would not capture the full dissemination risk.

The highest detection frequencies occurred among male patients, older patients, respiratory medicine cases, and sputum specimens, accounting respectively for 35 of 54, 39 of 54, 11 of 54, and 18 of 54 isolates. These distributions help identify where surveillance yielded the most detections, but they should not be interpreted as independent risk estimates without adjustment for admission volume, sampling intensity, comorbidities, or prior antibiotic exposure.

Comparison with Existing Internal Articles

The internal article Carbapenemase Gene Dynamics in CREC: Plasmid Transfer and Resistance presents the same study primarily through the relationship between plasmid carriage, resistance phenotype, and gene transfer. That framing is useful for researchers designing plasmid-focused experiments, while the reference article supplies the primary methodological and epidemiological detail needed to interpret those observations.

A second related summary, Transmission Dynamics of Carbapenemase Genes in CREC During COVID-19, emphasizes plasmid-borne blaNDM-1 and the high transfer rate. In comparison, the primary study adds important qualification by showing chromosomal-plus-plasmid carriage, mobile-element combinations, ERIC-PCR genotypes, hospital distribution, and gene-specific differences in transfer. These internal resources should therefore be treated as contextual summaries rather than independent validation cohorts.

Limitations and Transferability

The cohort is relatively modest and geographically restricted to eight teaching hospitals in one province. Its frequencies describe the sampled CREC population and cannot automatically be generalized to all Chinese hospitals, community isolates, or other Enterobacter species. The observational design also cannot establish that the COVID-19 period caused the resistance patterns; it can only characterize isolates collected within that epidemiological context.

Plasmid elimination followed by PCR is informative but does not provide sequence-resolved proof of plasmid architecture, copy number, integration sites, or the complete set of linked resistance genes. Whole-genome and long-read plasmid sequencing could refine the distinction between independent plasmids, chromosomal integration, and composite mobile elements. Likewise, conjugation demonstrates that transfer occurred under the selected laboratory conditions, not that the same event occurred between patients or within a hospital environment.

ERIC-PCR is useful for screening relatedness but generally offers lower resolution and less portability than modern genome-based typing. The observed associations with sex, age, department, and specimen type may also reflect healthcare utilization and sampling patterns. Despite these constraints, the study is transferable as a surveillance framework: laboratories can combine gene detection, localization, susceptibility testing, mobility assays, and strain typing to avoid overinterpreting any single result.

Research Support Resources

Why this cross-domain matters, maturity, and limitations

The reference study concerns clinical resistance surveillance, whereas plasmid selection assays are controlled molecular biology workflows. The connection is practical rather than evidentiary: a selection antibiotic can help maintain a research plasmid carrying a compatible marker, but it cannot establish carbapenemase carriage, prove clinical transmission, or replace susceptibility testing and genomic surveillance. This application is mature for construct maintenance, while its relevance to CREC epidemiology remains indirect.

Researchers can use Chloramphenicol (SKU A2512), also known as 2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide, to support compatible plasmid selection assay workflows. As an antimicrobial agent and bacterial protein synthesis inhibitor, it binds the bacterial 50S ribosomal subunit and produces protein synthesis inhibition. Selection conditions should be matched to the plasmid marker, host strain, and validated laboratory protocol; the reagent is intended for scientific research use rather than clinical or diagnostic use.